Skip to main content

Sulconazole Nitrate

Generic: Sulconazole Nitrate

Verified·Apr 23, 2026
Manufacturer
Sun
NDC
72143-311
RxCUI
106366
Route
TOPICAL
ICD-10 indication
B35.9

Affordability Check

How much will you actually pay for Sulconazole Nitrate?

In 30 seconds, see every legitimate way to afford Sulconazole Nitrate — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Sulconazole Nitrate

What is this medication? Sulconazole nitrate is a prescription antifungal medication primarily used to treat various types of fungal skin infections. It belongs to the class of drugs known as imidazoles and works by slowing or stopping the growth of fungi that cause skin irritation and damage. This medication is typically available as a topical cream or solution that is applied directly to the affected area of the skin to resolve the underlying infection.

Healthcare providers commonly prescribe this medication to treat conditions such as tinea pedis, which is known as athletes foot, and tinea cruris, commonly referred to as jock itch. It is also effective against tinea corporis, or ringworm, and tinea versicolor, a condition that results in discolored patches of skin. It is important for patients to complete the full course of treatment as directed by their physician to ensure the infection is completely eradicated and does not return.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Sulconazole Nitrate. Official source: DailyMed (NLM) · Label effective Dec 23, 2024

Indications and usage
INDICATIONS AND USAGE SULCONAZOLE NITRATE cream 1.0% is an antifungal agent indicated for the treatment of tinea pedis (athlete's foot), tinea cruris, and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagro- phytes, Epidermophyton floccosum , and Microsporum canis ,* and for the treatment of tinea versicolor.
Dosage and administration
DOSAGE AND ADMINISTRATION A small amount of cream should be gently massaged into the affected and surrounding skin areas once or twice daily, except in tinea pedis, where administration should be twice daily. Early relief of symptoms is experienced by the majority of patients and clinical improvement may be seen fairly soon after treatment is begun; however, tinea corporis/cruris and tinea versicolor should be treated for 3 weeks and tinea pedis for 4 weeks to reduce the possibility of recurrence. If significant clinical improvement is not seen after 4 to 6 weeks of treatment, an alternate diagnosis should be considered.
Contraindications
CONTRAINDICATIONS SULCONAZOLE NITRATE cream 1.0% is contraindicated in patients who have a history of hypersensitivity to any of its ingredients.
Adverse reactions
ADVERSE REACTIONS There were no systemic effects and only infrequent cutaneous adverse reactions in 1185 patients treated with sulconazole nitrate cream in controlled clinical trials. Approximately 3% of these patients reported itching, 3% burning or stinging, and 1% redness. These complaints did not usually interfere with treatment.
Use in pregnancy
Pregnancy There are no adequate and well-controlled studies in pregnant women. Sulconazole nitrate should be used during pregnancy only if clearly needed. Sulconazole nitrate has been shown to be embryotoxic in rats when given in doses of 125 times the adult human dose (in mg/kg). The drug was not teratogenic in rats or rabbits at oral doses of 50 mg/kg/day. Sulconazole nitrate given orally to rats at a dose 125 times the human dose resulted in prolonged gestation and dystocia. Several females died during the prenatal period, most likely due to labor complications.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.